Mounjaro 2.5 Mg/0.6ml Kwikpen 4 Doses is a once-weekly injectable medication approved by the FDA for lowering blood sugar in adults with type 2 diabetes. It may assist in weight loss but is not FDA approved for this purpose, working by increasing insulin production and reducing liver sugar production.
Key Features
- Active Ingredient: Tirzepatide
- Dosage Form: Injection (pre-filled pen)
- Administration: Subcutaneous injection
- Frequency: Once weekly
